NeurologyLive® Year in Review 2024: Most-Read FDA Approval Stories
Each year, the NeurologyLive® team tracks the progress of hundreds of therapeutic potentials through the clinical development pipeline. Eager to update the clinical community on the available options for the treatment of neurologic diseases, the staff is …